Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
9 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Wednesday, Nov 4 · in 69 days · 3 companies | |||||
| GOSS | Gossamer Bio, Inc. | Rare disease | $99.97M | +2.76% | |
| SCYX | SCYNEXIS, Inc. | Rare disease | $51.64M | +45.38% | |
| MCRB | Seres Therapeutics, Inc. | Rare disease | $46.81M | +3.09% | |
| Thursday, Nov 5 · in 70 days · 1 company | |||||
| ATYR | aTyr Pharma, Inc. | Rare disease | $55.91M | +16.33% | |
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| Tuesday, Nov 10 · in 75 days · 1 company |
| JSPR | Jasper Therapeutics, Inc. | Rare disease | $23.96M | +3.78% |
| Thursday, Nov 12 · in 77 days · 4 companies | |||||
| SPRO | Spero Therapeutics, Inc. | Rare disease | $70.76M | +4.24% | |
| QNCX | Quince Therapeutics, Inc. | Rare disease | $34.05M | +73.28% | |
| TVRD | Tvardi Therapeutics, Inc. | Rare disease | $23.74M | −28.35% | |
| JAGX | Jaguar Health, Inc. | Rare disease | $4.78M | −7.51% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.